Updated CIRSE Position Statement on the use of paclitaxel-coated balloons and stents in peripheral arterial disease
- Created: Monday, 08 April 2019 03:27
Dear IRSA members
IRSA would like to draw your attention to the following updated CIRSE press release regarding Paclitaxel coated and
eluting devices in the treatment of peripheral vascular disease. Further information can be found here.